Spectral Medical Inc. (TSE:EDT – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$1.33 and traded as high as C$1.36. Spectral Medical shares last traded at C$1.30, with a volume of 49,942 shares traded.
Spectral Medical Stock Down 3.7%
The firm has a 50 day moving average of C$1.33 and a two-hundred day moving average of C$1.33. The stock has a market capitalization of C$375.88 million, a PE ratio of -9.29 and a beta of 0.61. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03.
Spectral Medical (TSE:EDT – Get Free Report) last posted its earnings results on Friday, November 7th. The company reported C($0.11) earnings per share for the quarter. The business had revenue of C$0.68 million during the quarter. Equities research analysts anticipate that Spectral Medical Inc. will post -0.05 earnings per share for the current year.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.
Recommended Stories
- Five stocks we like better than Spectral Medical
- Your Bank Account Is No Longer Safe
- Trade this between 9:30 and 10:45 am EST
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
